## Abstract The problem of computing of the covalent and ionic species contribution to the chain building in propagation is discussed, and it is shown that under certain conditions the reversibility of propagation does not influence the contribution of the given species.
On the contribution of covalent and ionic species to the chain growth. Monte Carlo simulations and theoretical considerations
โ Scribed by Ryszard Szymanski
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 547 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1022-1344
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Contributions of the covalent and ionic species to the chain building in cationic reversible polymerizations are analyzed by means of Monte Carlo simulations and by solving the formulated set of equations. The validity of the equation for the contribution of covalent propagation, derived for reversible polymerization with simplifying assumptions, is discussed. It is shown that repeating units incorporated into the chain by covalent propagations are distributed uniformly only when direct monomer insertion into covalent bonds is not possible, or when intramolecular interconversion of covalent and ionic species is very fast in comparison with propagation.
๐ SIMILAR VOLUMES
## Abstract By use of the pivot algorithm, starโbranched chains with __F__ = 4, 8 and 12 arms of length __n__ and linear chains (__F__ = 2) are generated on a tetrahedral lattice (120 โค __nF__ โค 3 840). By taking into account nearest neighbour interactions (each contact contributes an energy ฯ __kT
## Abstract **Summary:** The effects of copolymer sequence distribution on the dynamics of a copolymer in a homopolymer matrix are studied using computer simulations within the framework of the bondโfluctuation model on blends containing low concentrations (10%) of copolymers dispersed in a homopol
## Abstract Divalproex sodium extendedโrelease (Depakote^ยฎ^ ER) is a once daily (QD) formulation for valproic acid that was developed to improve patient compliance and to reduce side effects compared with the standard twiceโdaily (BID) delayed release (DR) formulation (Depakote^ยฎ^ tablets). However